Serena Galosi

<i>KMT2B</i>-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation

Laura Cif, Diane Demailly, Jean‐Pierre Lin et al. · Brain · 2020 · 115 citations · Full text

Medicine, Molecular Genetics, Neurology +13

<i>GNAO1</i> encephalopathy

Federica Rachele Danti, Serena Galosi, Marta Romani et al. · Neurology Genetics · 2017 · 106 citations · Full text

Medicine, Molecular Genetics, Neurology +17

Frequency and phenotypic spectrum of <i>KMT2B</i> dystonia in childhood: A single‐center cohort study

Miryam Carecchio, Federica Invernizzi, Paulina González-Latapí et al. · Movement Disorders · 2019 · 83 citations

Life Sciences, Genetics, Neurology +17

<i>Caenorhabditis elegans</i> provides an efficient drug screening platform for <i>GNAO1</i> -related disorders and highlights the potential role of caffeine in controlling dyskinesia

Martina Di Rocco, Serena Galosi, Enrico Lanza et al. · Human Molecular Genetics · 2021 · 45 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

<i>De novo DHDDS</i> variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus

Serena Galosi, Ban H. Edani, Simone Martinelli et al. · Brain · 2021 · 42 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17